02/09/2022 - Abivax SA: ABIVAX: Abivax announces successful oversubscribed EUR 49.2M cross-over financing with top-tier US and European Biotech investors

[X]
Abivax: abivax announces successful oversubscribed eur 49.2m cross-over financing with top-tier us and european biotech investors

The text version of this document is not available. You can access the original document here.

Disclaimer

Abivax SA published this content on 02 September 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 September 2022 10:17:47 UTC.

MoneyController ti propone anche

Condividi